Moreover, by using an immunohistochemical approach, the expression of SGLT1 (together with BCL2 and p53) was analyzed in pancreatic cancer to relate the data obtained with different survival parameters. This evidence concerns the gene BCL2 and familial pancreatic carcinoma.